Delayed graft function of cadaveric renal transplants is prevented by diltiazem

Transplantation Proceedings

Volumn 28, Issue 1, 1996, Pages 80-82

  Carmellini, M ^a   Salvadori, M ^a   Di Stefano, R ^a   Bertoni, E ^a   Nicita, G ^a   Rosati, A ^a   Taddei, G ^a   Rindi, P ^a   Rizzo, G ^a   Mosca, F ^a  

^a CISANELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DILTIAZEM; METHYLPREDNISOLONE; OKT 3; PREDNISONE;

ADULT; CADAVER KIDNEY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; CADAVER; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MUROMONAB-CD3; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 0029917097     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)